JPS59104313A - 脂溶性ビタミン含有水性液 - Google Patents
脂溶性ビタミン含有水性液Info
- Publication number
- JPS59104313A JPS59104313A JP21269582A JP21269582A JPS59104313A JP S59104313 A JPS59104313 A JP S59104313A JP 21269582 A JP21269582 A JP 21269582A JP 21269582 A JP21269582 A JP 21269582A JP S59104313 A JPS59104313 A JP S59104313A
- Authority
- JP
- Japan
- Prior art keywords
- water
- active substance
- aqueous liquid
- hydrogenated
- fat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 23
- 229940088594 vitamin Drugs 0.000 title description 2
- 229930003231 vitamin Natural products 0.000 title description 2
- 235000013343 vitamin Nutrition 0.000 title description 2
- 239000011782 vitamin Substances 0.000 title description 2
- 239000013543 active substance Substances 0.000 claims abstract description 24
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000007864 aqueous solution Substances 0.000 claims abstract description 11
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 6
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229940046009 vitamin E Drugs 0.000 claims abstract description 6
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 6
- 239000011709 vitamin E Substances 0.000 claims abstract description 6
- 239000003021 water soluble solvent Substances 0.000 claims abstract description 6
- 239000000126 substance Substances 0.000 claims description 3
- 239000012929 tonicity agent Substances 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 29
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 abstract description 15
- 238000002834 transmittance Methods 0.000 abstract description 15
- 230000000694 effects Effects 0.000 abstract description 11
- 238000002347 injection Methods 0.000 abstract description 11
- 239000007924 injection Substances 0.000 abstract description 11
- 239000006185 dispersion Substances 0.000 abstract description 6
- 239000000243 solution Substances 0.000 abstract description 5
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 abstract description 4
- 229910052740 iodine Inorganic materials 0.000 abstract description 4
- 239000011630 iodine Substances 0.000 abstract description 4
- 239000003995 emulsifying agent Substances 0.000 abstract description 3
- 230000007774 longterm Effects 0.000 abstract description 3
- 150000003904 phospholipids Chemical class 0.000 abstract description 3
- 229930003448 Vitamin K Natural products 0.000 abstract 2
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 abstract 2
- 235000019168 vitamin K Nutrition 0.000 abstract 2
- 239000011712 vitamin K Substances 0.000 abstract 2
- 150000003721 vitamin K derivatives Chemical class 0.000 abstract 2
- 229940046010 vitamin k Drugs 0.000 abstract 2
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000007970 homogeneous dispersion Substances 0.000 abstract 1
- 229940099578 hydrogenated soybean lecithin Drugs 0.000 abstract 1
- 239000007951 isotonicity adjuster Substances 0.000 abstract 1
- 230000019612 pigmentation Effects 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 238000004040 coloring Methods 0.000 description 7
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 6
- 229940042585 tocopherol acetate Drugs 0.000 description 6
- -1 and in addition Chemical compound 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- 244000068988 Glycine max Species 0.000 description 4
- 235000010469 Glycine max Nutrition 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000000787 lecithin Substances 0.000 description 3
- 235000010445 lecithin Nutrition 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000009210 therapy by ultrasound Methods 0.000 description 3
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical class OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- AIXAANGOTKPUOY-UHFFFAOYSA-N carbachol Chemical compound [Cl-].C[N+](C)(C)CCOC(N)=O AIXAANGOTKPUOY-UHFFFAOYSA-N 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 235000013345 egg yolk Nutrition 0.000 description 2
- 210000002969 egg yolk Anatomy 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000005984 hydrogenation reaction Methods 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 108010030727 lens intermediate filament proteins Proteins 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 2
- 230000007928 solubilization Effects 0.000 description 2
- 238000005063 solubilization Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- ASWBNKHCZGQVJV-UHFFFAOYSA-N (3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COP([O-])(=O)OCC[N+](C)(C)C ASWBNKHCZGQVJV-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
- 244000267823 Hydrangea macrophylla Species 0.000 description 1
- 235000014486 Hydrangea macrophylla Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 235000002492 Rungia klossii Nutrition 0.000 description 1
- 244000117054 Rungia klossii Species 0.000 description 1
- 244000290333 Vanilla fragrans Species 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000013040 bath agent Substances 0.000 description 1
- 239000003788 bath preparation Substances 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000000078 claw Anatomy 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 description 1
- 229940099552 hyaluronan Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 235000014594 pastries Nutrition 0.000 description 1
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000010802 sludge Substances 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP21269582A JPS59104313A (ja) | 1982-12-06 | 1982-12-06 | 脂溶性ビタミン含有水性液 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP21269582A JPS59104313A (ja) | 1982-12-06 | 1982-12-06 | 脂溶性ビタミン含有水性液 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS59104313A true JPS59104313A (ja) | 1984-06-16 |
| JPH0213643B2 JPH0213643B2 (enrdf_load_stackoverflow) | 1990-04-04 |
Family
ID=16626893
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP21269582A Granted JPS59104313A (ja) | 1982-12-06 | 1982-12-06 | 脂溶性ビタミン含有水性液 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS59104313A (enrdf_load_stackoverflow) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS615011A (ja) * | 1984-06-18 | 1986-01-10 | Ss Pharmaceut Co Ltd | 安定なビタミンｅの可溶化液 |
| JPS6117512A (ja) * | 1984-07-03 | 1986-01-25 | Ss Pharmaceut Co Ltd | 低溶血性ビタミンｅ注射液 |
| JPS62106018A (ja) * | 1985-11-01 | 1987-05-16 | Santen Pharmaceut Co Ltd | 高濃度ビタミンｅ水性製剤 |
| JPS63188624A (ja) * | 1987-01-29 | 1988-08-04 | Maruzen Kasei Kk | ビタミンｅ含有水性液 |
| JPH01221312A (ja) * | 1988-03-01 | 1989-09-04 | Ss Pharmaceut Co Ltd | 脂溶性物質含有内服液 |
| EP0350864A1 (en) | 1988-07-11 | 1990-01-17 | Eisai Co., Ltd. | Aqueous solution containing fat-soluble vitamin K |
| US5162377A (en) * | 1988-06-20 | 1992-11-10 | Shiseido Company, Ltd. | Transparent composition |
-
1982
- 1982-12-06 JP JP21269582A patent/JPS59104313A/ja active Granted
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS615011A (ja) * | 1984-06-18 | 1986-01-10 | Ss Pharmaceut Co Ltd | 安定なビタミンｅの可溶化液 |
| JPS6117512A (ja) * | 1984-07-03 | 1986-01-25 | Ss Pharmaceut Co Ltd | 低溶血性ビタミンｅ注射液 |
| JPS62106018A (ja) * | 1985-11-01 | 1987-05-16 | Santen Pharmaceut Co Ltd | 高濃度ビタミンｅ水性製剤 |
| JPS63188624A (ja) * | 1987-01-29 | 1988-08-04 | Maruzen Kasei Kk | ビタミンｅ含有水性液 |
| JPH01221312A (ja) * | 1988-03-01 | 1989-09-04 | Ss Pharmaceut Co Ltd | 脂溶性物質含有内服液 |
| US5162377A (en) * | 1988-06-20 | 1992-11-10 | Shiseido Company, Ltd. | Transparent composition |
| EP0350864A1 (en) | 1988-07-11 | 1990-01-17 | Eisai Co., Ltd. | Aqueous solution containing fat-soluble vitamin K |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0213643B2 (enrdf_load_stackoverflow) | 1990-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR880002410B1 (ko) | 유비데카레논을 함유한 수성액의 제조방법 | |
| US4840970A (en) | Aqueous solution containing lipid-soluble pharmaceutical substance | |
| DK166752B1 (da) | Fremgangsmaade til fremstilling af praeparater med reguleret frigoerelse af biologisk aktive materialer | |
| JPS62228010A (ja) | 高度にフツ素化された有機化合物の安定乳濁液 | |
| DE3382637T2 (de) | Eine lipidloesliche substanz enthaltende waessrige fluessigkeit. | |
| JPH05509332A (ja) | 薬剤運搬のための非水性ミクロエマルジョン | |
| HUE033949T2 (hu) | Nátrium klorid oldat gyógyszer újraoldására vagy hígítására | |
| DE69232811T2 (de) | Infustionspräparat | |
| JPS5924132B2 (ja) | 栄養補給用乳剤の製法 | |
| JPS59104313A (ja) | 脂溶性ビタミン含有水性液 | |
| TW202038925A (zh) | 脂質體、含有脂質體的組成物、脂質體的製造方法及提高視黃醇的熱穩定性的方法 | |
| JP2010504290A (ja) | アラビアゴム含有エマルション | |
| CN113876658B (zh) | 水包油型乳液组合物及其制备方法 | |
| JPS60258110A (ja) | 静脈注射可能なプロゲステロン乳化注射液 | |
| KR920002326B1 (ko) | 지용성 비타민 k 함유 수용액 | |
| JPH06511482A (ja) | 滅菌濾過可能な作用物質溶液の製造方法 | |
| JPH02273619A (ja) | 脂溶性薬物含有水性液 | |
| JP2950348B2 (ja) | 脂肪乳剤及びその製造法 | |
| RU2329788C2 (ru) | Перфторуглеродно-жировые эмульсии с газотранспортными и энергетическими свойствами для медицинского назначения: состав, способ получения и средство для лечения | |
| JPS60260511A (ja) | 安定なエマルジヨン製剤 | |
| JP3615284B2 (ja) | 脂肪乳剤の製造法 | |
| JPS59161313A (ja) | 制癌剤を含有するエマルジヨン製剤 | |
| JPS60163819A (ja) | 肝油軟カプセル | |
| US1612598A (en) | Benzene | |
| JPS6379825A (ja) | 静脈注射用脂肪乳剤 |